2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
2019-08-31
SCID: 54.1/nfffnuf9
Discuss with AI
2019 ESC GuidelinesESC-EASD collaborationcardiovascular diseasesdiabetespre-diabetes
Figures from the paper
Abstract (AI)
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)
Key Findings
1
Clinicians remain responsible for verifying applicable rules and regulations regarding drugs and medical devices at the time of prescription.
2
Health professionals are encouraged to fully consider these Guidelines when exercising clinical judgment and determining preventive, diagnostic, or therapeutic strategies.
3
The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases were developed in collaboration with the EASD and reflect ESC views based on available scientific and medical evidence at publication time.
4
The ESC and EASD disclaim responsibility for contradictions between these Guidelines and other official public health recommendations; clinicians must also consider updated public health authority guidance.
5
The Guidelines do not override individual clinicians' responsibility to make patient-specific decisions in consultation with patients and caregivers.
Research Object
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases (developed with the EASD)
Research Subject
Recommendations and guidance for prevention, diagnosis, and management (therapeutic and healthcare strategies) of patients with diabetes, pre-diabetes, and cardiovascular diseases based on available scientific and medical evidence
Publication Details
Publication Date
2019-08-31
Journal
Publisher
ISSN
Cited by
4930
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai20
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin2002
2013 ESH/ESC Guidelines for the management of arterial hypertension2013
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2016
2018 ESC/ESH Guidelines for the management of arterial hypertension2018
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)2012
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation2015
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes2016
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes2008
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 20122012
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes2016
2016 European Guidelines on cardiovascular disease prevention in clinical practice2016
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS2016
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease2017
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes2015
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet2013
ESC/EAS Guidelines for the management of dyslipidaemias2011
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)2017
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes2014
Exercise and Type 2 Diabetes2010
Epidemiology of Peripheral Artery Disease2015
Cited by13
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2021
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice2021
2023 ESC Guidelines for the management of acute coronary syndromes2023
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension2023
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure2022
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease2020
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries2015
Arterial hypertension in adults. Clinical guidelines 20202020
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice2021
Multifunctional nanoparticle-mediated combining therapy for human diseases2023
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes2025
Ten things to know about ten cardiovascular disease risk factors – 20222022
Metabolic Approaches for the Treatment of Dilated Cardiomyopathy2023